Aptevo wins $1.5 million CARE Fund grant for APVO451 IND-enabling work
APVO•CARE Fund grant supports APVO451 development
- Aptevo secured a USD 1.5 million non-dilutive CARE Fund grant to support IND-enabling work for solid-tumor candidate APVO451.
- Funding targets development-candidate selection by year-end 2026; IND-enabling studies planned for 1Q27.



